Table 1.
Participant demographic characteristics.
| Variable | Solid carcinoma patients (N=298) |
Healthy controls (N=258) |
p |
|---|---|---|---|
| Sex | |||
| Male | 138 (46.3) | 114 (44.2) | 0.616 |
| Female | 160 (53.7) | 144 (55.8) | |
| Age, years | |||
| 18-59 | 117 (39.3) | 76 (29.5) | 0.015 |
| ≥60 | 181 (60.7) | 182 (70.5) | |
| Median (P25, P75 ) | 63 (53,71) | 67 (54,73) | |
| BMI (kg/m2) | |||
| <25.0 | 66 (22.1) | 188 (72.9) | 0.411 |
| ≥25.0 | 19 (6.4) | 69 (26.7) | |
| unknown | 213 (71.5) | 1 (0.4) | |
| Vaccine (s) administered | |||
| Yes | 177 (59.4) | 256 (99.2) | <0.001 |
| No | 121 (40.6) | 2 (0.8) | |
| COVID-19 infection | |||
| Yes | 234 (78.5) | 242 (93.8) | <0.001 |
| No | 64 (21.5) | 16 (6.2) | |
| Type of carcinoma | |||
| Lung carcinoma | 22 (7.4) | – | |
| Digestive carcinoma | 83 (27.9) | – | |
| Liver carcinoma | 21 (7.0) | – | |
| Breast carcinoma | 50 (16.8) | – | |
| Thyroid carcinoma | 21 (7.0) | – | |
| Prostate carcinoma | 32 (10.7) | – | |
| Other carcinomas | 70 (23.5) | – | |
Data are presented as number of participants (%) or median (P25, P75 ). aDigestive carcinoma (colorectal carcinoma, gastric carcinoma, pancreatic carcinoma, esophageal carcinoma, biliary tract carcinoma); bOther carcinomas (pituitary carcinoma; carcinomas of the mouth, nose, and throat; ovarian carcinomas; bladder carcinoma; renal carcinoma; ureter carcinoma; acoustic nerve carcinoma; uterine carcinoma). Statistical analyses were conducted using the Chi-squared test.